Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

ATXN7 anticorps (AA 354-381)

L’anticorps Lapin Polyclonal anti-ATXN7 a été validé pour WB. Il convient pour détecter ATXN7 dans des échantillons de Humain.
N° du produit ABIN1538351

Aperçu rapide pour ATXN7 anticorps (AA 354-381) (ABIN1538351)

Antigène

Voir toutes ATXN7 Anticorps
ATXN7 (Ataxin 7 (ATXN7))

Reactivité

  • 30
  • 28
  • 20
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
Humain

Hôte

  • 44
  • 1
Lapin

Clonalité

  • 44
  • 1
Polyclonal

Conjugué

  • 15
  • 4
  • 4
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp ATXN7 est non-conjugé

Application

  • 34
  • 19
  • 13
  • 13
  • 4
  • 3
  • 3
  • 2
  • 2
  • 1
Western Blotting (WB)

Clone

RB36286
  • Épitope

    • 15
    • 6
    • 6
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    AA 354-381

    Homologie

    M

    Purification

    This antibody is purified through a protein A column, followed by peptide affinity purification.

    Immunogène

    This ATXN7 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 354-381 amino acids from the Central region of human ATXN7.

    Isotype

    Ig Fraction
  • Indications d'application

    WB: 1:1000

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C,-20 °C

    Stockage commentaire

    ATXN7 Antibody (Center) can be refrigerated at 2-8 °C for up to 6 months. For long term storage, keep at -20 °C.

    Date de péremption

    6 months
  • Antigène

    ATXN7 (Ataxin 7 (ATXN7))

    Autre désignation

    ATXN7

    Sujet

    The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Clinically, ADCA has been divided into three groups: ADCA types I-III. ADCAI is genetically heterogeneous, with five genetic loci, designated spinocerebellar ataxia (SCA) 1, 2, 3, 4 and 6, being assigned to five different chromosomes. ADCAII, which always presents with retinal degeneration (SCA7), and ADCAIII often referred to as the 'pure' cerebellar syndrome (SCA5), are most likely homogeneous disorders. Several SCA genes have been cloned and shown to contain CAG repeats in their coding regions. ADCA is caused by the expansion of the CAG repeats, producing an elongated polyglutamine tract in the corresponding protein. The expanded repeats are variable in size and unstable, usually increasing in size when transmitted to successive generations. This locus has been mapped to chromosome 3, and it has been determined that the diseased allele associated with spinocerebellar ataxia-7 contains 38-130 CAG repeats (near the N-terminus), compared to 7-17 in the normal allele. The encoded protein is a component of the SPT3/TAF9/GCN5 acetyltransferase (STAGA) and TBP-free TAF-containing (TFTC) chromatin remodeling complexes, and it thus plays a role in transcriptional regulation. Alternative splicing results in multiple transcript variants.

    Poids moléculaire

    95451

    ID gène

    6314

    NCBI Accession

    NP_000324, NP_001121621, NP_001170858

    UniProt

    O15265
Vous êtes ici:
Chat with us!